Molecular control of the NEMO family of ubiquitin-binding proteins
Key Points NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin chains and in substrate recognition. NEMO interacts with linear (Met1-linked) ubiquitin dimers thro...
Gespeichert in:
Veröffentlicht in: | Nature reviews. Molecular cell biology 2013-10, Vol.14 (10), p.673-685 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 685 |
---|---|
container_issue | 10 |
container_start_page | 673 |
container_title | Nature reviews. Molecular cell biology |
container_volume | 14 |
creator | Clark, Kristopher Nanda, Sambit Cohen, Philip |
description | Key Points
NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin chains and in substrate recognition.
NEMO interacts with linear (Met1-linked) ubiquitin dimers through its UBAN (ubiquitin binding in ABIN and NEMO) domain. Disruption of this domain, for example by mutating Asp311 to Asn, prevents its recruitment to Met1-linked ubiquitin chains, reducing the activation of the canonical IKK complex by TGFβ-activated kinase 1 (TAK1) and the phosphorylation of its substrates.
Most of the Met1-linked ubiquitin oligomers formed in response to interleukin-1 (IL-1) are attached covalently to Lys63-linked ubiquitin oligomers, which may facilitate the activation of the canonical IKK complex by TAK1.
The NEMO–TANK (TRAF-associated NF-κB activator) complex facilitates crosstalk within the IKK family. Disruption of the complex interferes with the ability of the IKK-related kinases to limit the activation of the canonical IKKs, which is an important feedback control mechanism
in vivo
.
By regulating the activation of TANK-binding kinase 1 (TBK1) and IKKɛ, NEMO also controls the activation of the transcription factor IFN regulatory factor 3 (IRF3), which is required for the production of type I interferons.
The ubiquitin-binding domain of NEMO is also present in A20-binding inhibitor of NF-κB 1 (ABIN1), ABIN2, ABIN3 and optineurin, and ubiquitin binding to these proteins also regulates key molecular networks in the immune system.
Nuclear factor-κB (NF-κB) signalling is tightly regulated through ubiquitylation and phosphorylation of its components. Integral to this post-translational regulation is the polyubiquitin-binding protein NF-κB essential modulator (NEMO), which controls the modification of numerous NF-κB signalling proteins, such as the canonical IκB kinase (IKKs) and IKK-related kinases.
Research over the past decade has revealed how NF-κB essential modulator (NEMO; also known as IKKγ) regulates the IKKα–IKKβ signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the i |
doi_str_mv | 10.1038/nrm3644 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1436566460</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A347654868</galeid><sourcerecordid>A347654868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c509t-ac6dd8db2b19b3fc215c36bdb68a5d310d8b10cfba281ea54052ad58bae883423</originalsourceid><addsrcrecordid>eNptkUlLxTAUhYMozvgPpOBCXVSTZmi6VHECB3BYh0x9RtpEkxb035uHz-GJZJFw892bnHMA2ELwAEHMD33sMSNkAawiUqMSQg4Xv891tQLWUnqGEDFU02WwUuGGNw1tVsHxdeisHjsZCx38EENXhLYYnmxxc3p9W7Syd937tDQq9zq6wflSOW-cnxQvMQzW-bQBllrZJbs529fB49npw8lFeXV7fnlydFVqCpuhlJoZw42qFGoUbnWFqMZMGcW4pAYjaLhCULdKVhxZSQmklTSUK2k5x6TC62Dvc25--HW0aRC9S9p2nfQ2jEkgghlljDCY0Z0_6HMYo8-_yxRhTc2y_B9qIjsrnG_DEKWeDhVHmNSMEs54pg7-ofIytnfZM9u6XJ9r2J9rmPpq34aJHFMSl_d38-zuJ6tjSCnaVrxE18v4LhAU02TFLNlMbs8kjaq35pv7ivLHnpSv_MTGX5r_zPoAuqSojA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1446976899</pqid></control><display><type>article</type><title>Molecular control of the NEMO family of ubiquitin-binding proteins</title><source>MEDLINE</source><source>Nature Journals Online</source><source>SpringerLink Journals - AutoHoldings</source><creator>Clark, Kristopher ; Nanda, Sambit ; Cohen, Philip</creator><creatorcontrib>Clark, Kristopher ; Nanda, Sambit ; Cohen, Philip</creatorcontrib><description>Key Points
NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin chains and in substrate recognition.
NEMO interacts with linear (Met1-linked) ubiquitin dimers through its UBAN (ubiquitin binding in ABIN and NEMO) domain. Disruption of this domain, for example by mutating Asp311 to Asn, prevents its recruitment to Met1-linked ubiquitin chains, reducing the activation of the canonical IKK complex by TGFβ-activated kinase 1 (TAK1) and the phosphorylation of its substrates.
Most of the Met1-linked ubiquitin oligomers formed in response to interleukin-1 (IL-1) are attached covalently to Lys63-linked ubiquitin oligomers, which may facilitate the activation of the canonical IKK complex by TAK1.
The NEMO–TANK (TRAF-associated NF-κB activator) complex facilitates crosstalk within the IKK family. Disruption of the complex interferes with the ability of the IKK-related kinases to limit the activation of the canonical IKKs, which is an important feedback control mechanism
in vivo
.
By regulating the activation of TANK-binding kinase 1 (TBK1) and IKKɛ, NEMO also controls the activation of the transcription factor IFN regulatory factor 3 (IRF3), which is required for the production of type I interferons.
The ubiquitin-binding domain of NEMO is also present in A20-binding inhibitor of NF-κB 1 (ABIN1), ABIN2, ABIN3 and optineurin, and ubiquitin binding to these proteins also regulates key molecular networks in the immune system.
Nuclear factor-κB (NF-κB) signalling is tightly regulated through ubiquitylation and phosphorylation of its components. Integral to this post-translational regulation is the polyubiquitin-binding protein NF-κB essential modulator (NEMO), which controls the modification of numerous NF-κB signalling proteins, such as the canonical IκB kinase (IKKs) and IKK-related kinases.
Research over the past decade has revealed how NF-κB essential modulator (NEMO; also known as IKKγ) regulates the IKKα–IKKβ signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the interplay between phosphorylation and ubiquitylation controls cell signalling networks in health and disease.</description><identifier>ISSN: 1471-0072</identifier><identifier>EISSN: 1471-0080</identifier><identifier>DOI: 10.1038/nrm3644</identifier><identifier>PMID: 23989959</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/250 ; 631/337/458/582 ; 631/80/458 ; 631/80/86 ; Binding proteins ; Biochemistry ; Cancer Research ; Cell Biology ; Cellular control mechanisms ; Developmental Biology ; Fibroblasts ; Humans ; I-kappa B Kinase - genetics ; I-kappa B Kinase - immunology ; Immune system ; Immunity, Innate - genetics ; Kinases ; Life Sciences ; Mutation ; NF-kappa B - genetics ; NF-kappa B - metabolism ; Phosphorylation ; Physiology ; Polyubiquitin - genetics ; Polyubiquitin - metabolism ; Properties ; Protein Binding ; Proteins ; review-article ; Signal Transduction ; Stem Cells ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-TNF</subject><ispartof>Nature reviews. Molecular cell biology, 2013-10, Vol.14 (10), p.673-685</ispartof><rights>Springer Nature Limited 2013</rights><rights>COPYRIGHT 2013 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Oct 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c509t-ac6dd8db2b19b3fc215c36bdb68a5d310d8b10cfba281ea54052ad58bae883423</citedby><cites>FETCH-LOGICAL-c509t-ac6dd8db2b19b3fc215c36bdb68a5d310d8b10cfba281ea54052ad58bae883423</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nrm3644$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nrm3644$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23989959$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clark, Kristopher</creatorcontrib><creatorcontrib>Nanda, Sambit</creatorcontrib><creatorcontrib>Cohen, Philip</creatorcontrib><title>Molecular control of the NEMO family of ubiquitin-binding proteins</title><title>Nature reviews. Molecular cell biology</title><addtitle>Nat Rev Mol Cell Biol</addtitle><addtitle>Nat Rev Mol Cell Biol</addtitle><description>Key Points
NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin chains and in substrate recognition.
NEMO interacts with linear (Met1-linked) ubiquitin dimers through its UBAN (ubiquitin binding in ABIN and NEMO) domain. Disruption of this domain, for example by mutating Asp311 to Asn, prevents its recruitment to Met1-linked ubiquitin chains, reducing the activation of the canonical IKK complex by TGFβ-activated kinase 1 (TAK1) and the phosphorylation of its substrates.
Most of the Met1-linked ubiquitin oligomers formed in response to interleukin-1 (IL-1) are attached covalently to Lys63-linked ubiquitin oligomers, which may facilitate the activation of the canonical IKK complex by TAK1.
The NEMO–TANK (TRAF-associated NF-κB activator) complex facilitates crosstalk within the IKK family. Disruption of the complex interferes with the ability of the IKK-related kinases to limit the activation of the canonical IKKs, which is an important feedback control mechanism
in vivo
.
By regulating the activation of TANK-binding kinase 1 (TBK1) and IKKɛ, NEMO also controls the activation of the transcription factor IFN regulatory factor 3 (IRF3), which is required for the production of type I interferons.
The ubiquitin-binding domain of NEMO is also present in A20-binding inhibitor of NF-κB 1 (ABIN1), ABIN2, ABIN3 and optineurin, and ubiquitin binding to these proteins also regulates key molecular networks in the immune system.
Nuclear factor-κB (NF-κB) signalling is tightly regulated through ubiquitylation and phosphorylation of its components. Integral to this post-translational regulation is the polyubiquitin-binding protein NF-κB essential modulator (NEMO), which controls the modification of numerous NF-κB signalling proteins, such as the canonical IκB kinase (IKKs) and IKK-related kinases.
Research over the past decade has revealed how NF-κB essential modulator (NEMO; also known as IKKγ) regulates the IKKα–IKKβ signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the interplay between phosphorylation and ubiquitylation controls cell signalling networks in health and disease.</description><subject>631/250</subject><subject>631/337/458/582</subject><subject>631/80/458</subject><subject>631/80/86</subject><subject>Binding proteins</subject><subject>Biochemistry</subject><subject>Cancer Research</subject><subject>Cell Biology</subject><subject>Cellular control mechanisms</subject><subject>Developmental Biology</subject><subject>Fibroblasts</subject><subject>Humans</subject><subject>I-kappa B Kinase - genetics</subject><subject>I-kappa B Kinase - immunology</subject><subject>Immune system</subject><subject>Immunity, Innate - genetics</subject><subject>Kinases</subject><subject>Life Sciences</subject><subject>Mutation</subject><subject>NF-kappa B - genetics</subject><subject>NF-kappa B - metabolism</subject><subject>Phosphorylation</subject><subject>Physiology</subject><subject>Polyubiquitin - genetics</subject><subject>Polyubiquitin - metabolism</subject><subject>Properties</subject><subject>Protein Binding</subject><subject>Proteins</subject><subject>review-article</subject><subject>Signal Transduction</subject><subject>Stem Cells</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-TNF</subject><issn>1471-0072</issn><issn>1471-0080</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNptkUlLxTAUhYMozvgPpOBCXVSTZmi6VHECB3BYh0x9RtpEkxb035uHz-GJZJFw892bnHMA2ELwAEHMD33sMSNkAawiUqMSQg4Xv891tQLWUnqGEDFU02WwUuGGNw1tVsHxdeisHjsZCx38EENXhLYYnmxxc3p9W7Syd937tDQq9zq6wflSOW-cnxQvMQzW-bQBllrZJbs529fB49npw8lFeXV7fnlydFVqCpuhlJoZw42qFGoUbnWFqMZMGcW4pAYjaLhCULdKVhxZSQmklTSUK2k5x6TC62Dvc25--HW0aRC9S9p2nfQ2jEkgghlljDCY0Z0_6HMYo8-_yxRhTc2y_B9qIjsrnG_DEKWeDhVHmNSMEs54pg7-ofIytnfZM9u6XJ9r2J9rmPpq34aJHFMSl_d38-zuJ6tjSCnaVrxE18v4LhAU02TFLNlMbs8kjaq35pv7ivLHnpSv_MTGX5r_zPoAuqSojA</recordid><startdate>20131001</startdate><enddate>20131001</enddate><creator>Clark, Kristopher</creator><creator>Nanda, Sambit</creator><creator>Cohen, Philip</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7RV</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BKSAR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PCBAR</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20131001</creationdate><title>Molecular control of the NEMO family of ubiquitin-binding proteins</title><author>Clark, Kristopher ; Nanda, Sambit ; Cohen, Philip</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c509t-ac6dd8db2b19b3fc215c36bdb68a5d310d8b10cfba281ea54052ad58bae883423</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>631/250</topic><topic>631/337/458/582</topic><topic>631/80/458</topic><topic>631/80/86</topic><topic>Binding proteins</topic><topic>Biochemistry</topic><topic>Cancer Research</topic><topic>Cell Biology</topic><topic>Cellular control mechanisms</topic><topic>Developmental Biology</topic><topic>Fibroblasts</topic><topic>Humans</topic><topic>I-kappa B Kinase - genetics</topic><topic>I-kappa B Kinase - immunology</topic><topic>Immune system</topic><topic>Immunity, Innate - genetics</topic><topic>Kinases</topic><topic>Life Sciences</topic><topic>Mutation</topic><topic>NF-kappa B - genetics</topic><topic>NF-kappa B - metabolism</topic><topic>Phosphorylation</topic><topic>Physiology</topic><topic>Polyubiquitin - genetics</topic><topic>Polyubiquitin - metabolism</topic><topic>Properties</topic><topic>Protein Binding</topic><topic>Proteins</topic><topic>review-article</topic><topic>Signal Transduction</topic><topic>Stem Cells</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-TNF</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clark, Kristopher</creatorcontrib><creatorcontrib>Nanda, Sambit</creatorcontrib><creatorcontrib>Cohen, Philip</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Earth, Atmospheric & Aquatic Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Earth, Atmospheric & Aquatic Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Nature reviews. Molecular cell biology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clark, Kristopher</au><au>Nanda, Sambit</au><au>Cohen, Philip</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Molecular control of the NEMO family of ubiquitin-binding proteins</atitle><jtitle>Nature reviews. Molecular cell biology</jtitle><stitle>Nat Rev Mol Cell Biol</stitle><addtitle>Nat Rev Mol Cell Biol</addtitle><date>2013-10-01</date><risdate>2013</risdate><volume>14</volume><issue>10</issue><spage>673</spage><epage>685</epage><pages>673-685</pages><issn>1471-0072</issn><eissn>1471-0080</eissn><abstract>Key Points
NF-κB essential modulator (NEMO) is an integral regulatory component of the canonical IκB kinase (IKK) complex that has key roles in controlling the activation of IKKα and IKKβ by ubiquitin chains and in substrate recognition.
NEMO interacts with linear (Met1-linked) ubiquitin dimers through its UBAN (ubiquitin binding in ABIN and NEMO) domain. Disruption of this domain, for example by mutating Asp311 to Asn, prevents its recruitment to Met1-linked ubiquitin chains, reducing the activation of the canonical IKK complex by TGFβ-activated kinase 1 (TAK1) and the phosphorylation of its substrates.
Most of the Met1-linked ubiquitin oligomers formed in response to interleukin-1 (IL-1) are attached covalently to Lys63-linked ubiquitin oligomers, which may facilitate the activation of the canonical IKK complex by TAK1.
The NEMO–TANK (TRAF-associated NF-κB activator) complex facilitates crosstalk within the IKK family. Disruption of the complex interferes with the ability of the IKK-related kinases to limit the activation of the canonical IKKs, which is an important feedback control mechanism
in vivo
.
By regulating the activation of TANK-binding kinase 1 (TBK1) and IKKɛ, NEMO also controls the activation of the transcription factor IFN regulatory factor 3 (IRF3), which is required for the production of type I interferons.
The ubiquitin-binding domain of NEMO is also present in A20-binding inhibitor of NF-κB 1 (ABIN1), ABIN2, ABIN3 and optineurin, and ubiquitin binding to these proteins also regulates key molecular networks in the immune system.
Nuclear factor-κB (NF-κB) signalling is tightly regulated through ubiquitylation and phosphorylation of its components. Integral to this post-translational regulation is the polyubiquitin-binding protein NF-κB essential modulator (NEMO), which controls the modification of numerous NF-κB signalling proteins, such as the canonical IκB kinase (IKKs) and IKK-related kinases.
Research over the past decade has revealed how NF-κB essential modulator (NEMO; also known as IKKγ) regulates the IKKα–IKKβ signalling axis in the innate immune system. The discovery that NEMO is a polyubiquitin-binding protein and that the IKK complex is modulated by other protein kinases that are themselves controlled by polyubiquitin chains has provided a deeper molecular understanding of the non-degradative roles of ubiquitylation. New mechanistic insights of NEMO and related polyubiquitin-binding proteins have become a paradigm for how the interplay between phosphorylation and ubiquitylation controls cell signalling networks in health and disease.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>23989959</pmid><doi>10.1038/nrm3644</doi><tpages>13</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1471-0072 |
ispartof | Nature reviews. Molecular cell biology, 2013-10, Vol.14 (10), p.673-685 |
issn | 1471-0072 1471-0080 |
language | eng |
recordid | cdi_proquest_miscellaneous_1436566460 |
source | MEDLINE; Nature Journals Online; SpringerLink Journals - AutoHoldings |
subjects | 631/250 631/337/458/582 631/80/458 631/80/86 Binding proteins Biochemistry Cancer Research Cell Biology Cellular control mechanisms Developmental Biology Fibroblasts Humans I-kappa B Kinase - genetics I-kappa B Kinase - immunology Immune system Immunity, Innate - genetics Kinases Life Sciences Mutation NF-kappa B - genetics NF-kappa B - metabolism Phosphorylation Physiology Polyubiquitin - genetics Polyubiquitin - metabolism Properties Protein Binding Proteins review-article Signal Transduction Stem Cells Tumor Necrosis Factor-alpha - metabolism Tumor necrosis factor-TNF |
title | Molecular control of the NEMO family of ubiquitin-binding proteins |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T06%3A27%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Molecular%20control%20of%20the%20NEMO%20family%20of%20ubiquitin-binding%20proteins&rft.jtitle=Nature%20reviews.%20Molecular%20cell%20biology&rft.au=Clark,%20Kristopher&rft.date=2013-10-01&rft.volume=14&rft.issue=10&rft.spage=673&rft.epage=685&rft.pages=673-685&rft.issn=1471-0072&rft.eissn=1471-0080&rft_id=info:doi/10.1038/nrm3644&rft_dat=%3Cgale_proqu%3EA347654868%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1446976899&rft_id=info:pmid/23989959&rft_galeid=A347654868&rfr_iscdi=true |